Shenzhen Edge Medical Co., Ltd. (“Edge Medical”) announced that its Board plans to revise the company’s Articles of Association and will seek shareholder approval via special resolution at the forthcoming annual general meeting (AGM).
The proposed amendments focus on three areas: 1. Updating the company’s registered address. 2. Allowing greater flexibility for general meetings, including the option to hold hybrid meetings. 3. Incorporating housekeeping changes following Edge Medical’s successful listing on The Stock Exchange of Hong Kong Limited.
A circular detailing the amendments and the AGM notice will be distributed to shareholders in due course.
The Board is chaired by Executive Director Dr. Wang Jianchen. As of the announcement date, the Board consists of three executive directors, three non-executive directors and three independent non-executive directors. The announcement was released in Hong Kong on 1 June 2026.
Comments